Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion type Assertion NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_head.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion description "[HTR2A was up-regulated in CFS through allele-specific expression modulated by transcription factors at critical sites in its promoter: an E47 binding site at position -1,438, (created by the A-allele of rs6311 polymorphism), a glucocorticoid receptor (GR) binding site encompassing a CpG at position -1,420, and Sp1 binding at CpG methylation site -1,224.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_provenance.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion evidence source_evidence_literature NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_provenance.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion SIO_000772 20941551 NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_provenance.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion wasDerivedFrom befree-20150227 NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_provenance.
- NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_assertion wasGeneratedBy ECO_0000203 NP471348.RAypLVNw6xD-CjMIGAdZ8e4A8Tpia73_T5nnMwxxEd49o130_provenance.